VIVXF (VIVXF) Stock Price & Analysis
VIVXF (VIVXF) rose 0.00% to USD 0 as of June 10, 2026 at 07:51 UTC, according to Nexqual real-time market data.
VIVXF last closed at USD 0; the session ranged USD 0–0 on volume of 100 shares. Market capitalization is $12,509, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 07:51 UTC.
Key Statistics (as of June 10, 2026 at 07:51 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 100 shares |
| Market Cap | $12,509 |
| Exchange | PNK |
Technical Analysis (VIVXF)
Nexqual's technical model rates VIVXF "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 07:51 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (VIVXF)
Wall Street analysts rate VIVXF "None", per Nexqual as of June 10, 2026 at 07:51 UTC.
| Consensus Rating | None |
|---|
Earnings (VIVXF)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2022-10-31 | USD -0.02 vs est -0.02 ▲ beat |
| 2022-07-31 | USD -0.03 vs est -0.02 ▼ miss |
| 2022-04-30 | USD -0.02 vs est -0.02 ▲ beat |
| 2022-01-31 | USD -0.03 vs est -0.03 ▲ beat |
Source: Nexqual, June 10, 2026 at 07:51 UTC.
Financials & Fundamentals (VIVXF)
| Total Revenue | $715,219 |
|---|---|
| Revenue Growth (YoY) | -16.60% |
| Gross Margin | +42.70% |
| Operating Margin | -1047.35% |
| Profit Margin | +0.00% |
| Current Ratio | 0.03 |
| Total Cash | $17,183 |
| Total Debt | $7.24M |
| Free Cash Flow | $-851,402 |
Source: Nexqual, June 10, 2026 at 07:51 UTC.
Financial Health Score (VIVXF)
Nexqual rates VIVXF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 07:51 UTC.
| Growth | Critical — Revenue -28% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $17K cash vs $7M debt |
| Cash Flow | Weak — FCF negative: -$851K, burning cash |
| Efficiency | Mixed — No data |
Ownership (VIVXF)
| Insider Ownership | +1.11% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 77.69M |
| Float | 76.60M |
Source: Nexqual, June 10, 2026 at 07:51 UTC.
Leadership (VIVXF)
VIVXF is led by G. F. Kym Anthony (age 69), CEO & Vice Chairman, per Nexqual as of June 10, 2026 at 07:51 UTC.
| CEO & Vice Chairman | G. F. Kym Anthony (age 69) |
|---|---|
| Interim Chief Financial Officer | Ira Levy |
| Director of Investor Relations | Drew Basek |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NMTRQ | 9 Meters Biopharma, Inc. | USD 0 | ▲ 0% |
| ACBM | ACRO BIOMEDICAL CO LTD | USD 0.03 | ▲ 0% |
| INLB | ITEM 9 LABS CORP | USD 0 | ▲ 0% |
| YOURF | YOURWAY CANNABIS BRANDS INC | USD 0 | ▲ 0% |
| HSCHF | H-SOURCE HOLDINGS LTD | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:51 UTC. This page is informational and not investment advice.